(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis

Hicham Skali1, Allison R Schulman, Sharmila Dorbala

  • 1Department of Radiology, Division of Nuclear Medicine and Molecular imaging, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA 02115, USA.

Insights

Diagnosing cardiac sarcoidosis is challenging. Fluorodeoxyglucose-positron emission tomography (FDG-PET) shows promise for assessing disease activity and guiding treatment in patients with cardiac sarcoidosis.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Immunology

Background:

  • Cardiac sarcoidosis significantly worsens prognosis.
  • Nonspecific symptoms and patchy myocardial involvement complicate early diagnosis.
  • A standardized diagnostic approach for cardiac sarcoidosis is lacking.

Purpose of the Study:

  • To highlight the utility of imaging modalities for cardiac sarcoidosis.
  • To emphasize the role of (18)F-FDG PET in assessing disease activity and treatment response.
  • To support the use of (18)F-FDG PET in diagnosis and risk stratification.

Main Methods:

  • Review of current literature on cardiac sarcoidosis diagnosis and management.
  • Focus on the application and advantages of (18)F-FDG PET imaging.
  • Analysis of data supporting (18)F-FDG PET's role in clinical practice.

Main Results:

  • Early diagnosis of cardiac sarcoidosis remains difficult due to nonspecific manifestations.
  • (18)F-FDG PET offers practical advantages for assessing disease activity.
  • (18)F-FDG PET aids in monitoring treatment response and risk stratification.

Conclusions:

  • Effective management of cardiac sarcoidosis requires imaging that identifies disease and predicts therapy response.
  • (18)F-FDG PET is a valuable tool for diagnosing and managing cardiac sarcoidosis.
  • Growing evidence supports the use of (18)F-FDG PET in cardiac sarcoidosis.

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...